Phase 2/3 Study of ALK-001 in Geographic Atrophy

NCT03845582 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Geographic Atrophy
Age Related Macular Degeneration
AMD
Atrophy, Geographic

Interventions

DRUG: ALK-001 oral capsule
DRUG: Placebo oral capsule

Sponsor

Alkeus Pharmaceuticals, Inc.